IHS Chemical Week

World News and Views :: Top of the News

FDA accepts Sanofi's new diabetes drug application

11:41 PM MDT | July 7, 2014 | Natasha Alperowicz

Sanofi (Paris) said today that the US FDA has accepted for review the company’s new drug application for Toujeo, an investigational basal insulin. This follows the acceptance of the marketing authorization dossier for Toujeo by the European Medicine Agency for EU countries on 27 May 2014. “By reaching this key milestone in the approval process, we are pleased to take another step forward with Toujeo, an investigational new based insulin that has been evaluated in a broad range of people living with diabetes,” said Pierre Chancel, senior...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa